Gilead Sciences, Inc.
Principal Scientist, Analytical Ops
Gilead Sciences, Inc., Oceanside, California, United States, 92058
**Responsibilities:*** Accountable for:* + Defining and managing rapid testing strategies to support process development and process characterization studies, including documentation of data and IQ/OQ commensurate with the level of the data use (e.g. data used to set GMP specifications)
+ Driving continuous improvement of rapid testing to increase throughput and quality of data
+ Support the design/justification/execution of how rapid testing data supports the end-to-end control strategy development through a proactive definition of the product quality targets.
+ Delivering high quality work packages for supporting Pivotal INDa and marketing applications.* Serve as an analytical project lead for late-phase program overseeing all analytical deliverables.* Serve as an author and reviewer of CMC sections in regulatory filings, and support interactions with health agencies.* Collaborate across Gilead Pharmaceutical Development & Manufacturing (PDM) and partner with Quality, Supply Chain, Manufacturing, CMC Regulatory Affairs, Clinical Development and Technical Development to ensure timely delivery and successful commercialization of the late-stage Biologics portfolio.* Act as a key member of the extended Analytical Development leadership team to shape late-stage development strategies.* Demonstrate comprehensive knowledge in key analytical CMC strategic areas including CQAs, separations methods, method bridging, reference standard, comparability, and specifications.* Drive for the adoption of novel and state-of-the-art characterization technologies and approaches.* Recruit, hire, and mentor talent to help cultivate a world class Biologics AD organization.**Basic Qualifications:*** Ph.D. with 8+ years or M.S. with 10+ years in Analytical Chemistry or related fields of industrial experience in biologics analytical development and/or structural characterization with people leader accountabilities.* Significant expertise in rapid testing instrumentation, automation and data processing.* Experience with technologies may include but not limited to Mass spectrometry, Analytical ultracentrifugation (AUC), Size exclusion chromatography (SEC), Reversed phase chromatography, Ion exchange chromatography (IEX), Capillary gel electrophoresis (CGE), Light scattering techniques (DLS, MALS) and Molecular analysis.* Subject matter expert in establishing comprehensive control strategies for biologics products.* Well versed in FDA and ICH guidelines relating to registration, quality, and compliance concerning drug substance and drug product.* Proven track record in drafting regulatory documentation at all stages, including IND, BLA, and PAS filings.* Demonstrated ability of building strong collaborations with other CMC functions.* Strong business acumen, with ability to balance resource, budget, and program milestones.* Working knowledge of lab automation, computer validation, data governance, data science, knowledge management and data protection.* Leadership qualities of the successful candidate include the following: collaboration, building and developing high performing teams, accountability, cross functional engagement and influence, program management, strategic vision, executive presence. Ability to build high performing teams and to set clear and measurable goals for staff and prioritize projects and resources.* Create inclusion - knowing the business value of diverse teams, modeling inclusion, and embedding the value of diversity in the way they manage their teams.* Develop talent - understand the skills, experience, aspirations and potential of their employees and coach them on current performance and future potential. They ensure employees are receiving the feedback and insight needed to grow, develop and realize their purpose.* Empower teams - connect the team to the organization by aligning goals, purpose, and organizational objectives, and holding them to account. They provide the support needed to remove barriers and connect their team to the broader ecosystem. #J-18808-Ljbffr
+ Driving continuous improvement of rapid testing to increase throughput and quality of data
+ Support the design/justification/execution of how rapid testing data supports the end-to-end control strategy development through a proactive definition of the product quality targets.
+ Delivering high quality work packages for supporting Pivotal INDa and marketing applications.* Serve as an analytical project lead for late-phase program overseeing all analytical deliverables.* Serve as an author and reviewer of CMC sections in regulatory filings, and support interactions with health agencies.* Collaborate across Gilead Pharmaceutical Development & Manufacturing (PDM) and partner with Quality, Supply Chain, Manufacturing, CMC Regulatory Affairs, Clinical Development and Technical Development to ensure timely delivery and successful commercialization of the late-stage Biologics portfolio.* Act as a key member of the extended Analytical Development leadership team to shape late-stage development strategies.* Demonstrate comprehensive knowledge in key analytical CMC strategic areas including CQAs, separations methods, method bridging, reference standard, comparability, and specifications.* Drive for the adoption of novel and state-of-the-art characterization technologies and approaches.* Recruit, hire, and mentor talent to help cultivate a world class Biologics AD organization.**Basic Qualifications:*** Ph.D. with 8+ years or M.S. with 10+ years in Analytical Chemistry or related fields of industrial experience in biologics analytical development and/or structural characterization with people leader accountabilities.* Significant expertise in rapid testing instrumentation, automation and data processing.* Experience with technologies may include but not limited to Mass spectrometry, Analytical ultracentrifugation (AUC), Size exclusion chromatography (SEC), Reversed phase chromatography, Ion exchange chromatography (IEX), Capillary gel electrophoresis (CGE), Light scattering techniques (DLS, MALS) and Molecular analysis.* Subject matter expert in establishing comprehensive control strategies for biologics products.* Well versed in FDA and ICH guidelines relating to registration, quality, and compliance concerning drug substance and drug product.* Proven track record in drafting regulatory documentation at all stages, including IND, BLA, and PAS filings.* Demonstrated ability of building strong collaborations with other CMC functions.* Strong business acumen, with ability to balance resource, budget, and program milestones.* Working knowledge of lab automation, computer validation, data governance, data science, knowledge management and data protection.* Leadership qualities of the successful candidate include the following: collaboration, building and developing high performing teams, accountability, cross functional engagement and influence, program management, strategic vision, executive presence. Ability to build high performing teams and to set clear and measurable goals for staff and prioritize projects and resources.* Create inclusion - knowing the business value of diverse teams, modeling inclusion, and embedding the value of diversity in the way they manage their teams.* Develop talent - understand the skills, experience, aspirations and potential of their employees and coach them on current performance and future potential. They ensure employees are receiving the feedback and insight needed to grow, develop and realize their purpose.* Empower teams - connect the team to the organization by aligning goals, purpose, and organizational objectives, and holding them to account. They provide the support needed to remove barriers and connect their team to the broader ecosystem. #J-18808-Ljbffr